DiscoverListen to Gynecologic Oncology
Listen to Gynecologic Oncology
Claim Ownership

Listen to Gynecologic Oncology

Author: Gynecologic Oncology

Subscribed: 31Played: 234
Share

Description

Stay informed with the latest research and emerging topics in gynecologic oncology through our monthly podcast series. Each episode features a dynamic conversation hosted by one of our Journal’s esteemed editors, who speaks with the authors of the Editor’s Choice article and the accompanying commentaryl.

5 Episodes
Reverse
In good SHAPE

In good SHAPE

2026-02-0123:45

Editor Choice: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial Hosted by: Gregg Nelson, MD, PhD, FRCSC University of Calgary, Calgary, Alberta Canada Featuring: Janice S. Kwon MD, MPH, FRCSC, University of British Columbia, Vancouver, Canada and R. Wendel Naumann, MD Atrium He...
Editor’s Choice: Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment? Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Rebecca Arhend, University of Alabama at Birmingham, Birmingham, AL, USA Christina M. Annunziata, American Cancer Society, Atlanta, GA, USA https://www.gynecologiconcology-online.net/article/S0090-8258(25)01083-2/ https://www.gynecologiconcology-online.net/a...
Editor’s Choice: Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approaches Hosted by: Paola A Gehrig, MD University of Virginia Charlottesville, Virginia United States Featuring: Lee-may Chen, MD; Division of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States Esther Vermaas; Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, Amsterdam UMC location Vrije Universite...
Editor’s Choice: Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net
Editor’s Choice: Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net
Comments